Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Performance and Safety of Mepilex® Up in Leg and Foot Ulcers and Skin Tears

NCT: NCT07782008 · NOT_YET_RECRUITING

NCT IDNCT07782008
StatusNOT_YET_RECRUITING
Start Date2026-08-31
Completion2027-09-30
SponsorMolnlycke Health Care AB (INDUSTRY)
First posted
Last updated

Brief Summary

This post-market clinical follow-up investigation is designed to evaluate the performance and safety of Mepilex® Up when used for the management of exuding ulcers and skin tears on the leg and foot. Approximately 70 adult participants will be treated with Mepilex® Up and followed for up to 6 weeks to assess wound progression and safety.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑